# The Kashima Scan Study 2: a protocol for a prospective observational cohort study of cerebral small vessel disease in neurologically healthy adults

## TL;DR

This study aims to understand how lifestyle, genetics, and socioeconomic factors influence brain health and disease outcomes in a Japanese cohort over 10 years.

## Contribution

The study introduces a new protocol that includes genetic and socioeconomic factors to better understand cerebral small vessel disease progression.

## Key findings

- The study will examine interactions between genetic background and lifestyle factors in relation to cognitive impairment.
- It will track outcomes such as vascular events and death over a 10-year follow-up period.
- The cohort includes 908 healthy Japanese adults aged 35 to 84 years.

## Abstract

Our previous observational cohort study, the Kashima Scan Study (KSS), identified associations between lifestyle, cerebral small vessel disease (SVD) as detected by magnetic resonance imaging of the brain, and disease outcomes including cognitive impairment and vascular diseases. However, established modifiers of the outcomes such as genetic background, drinking and exercise habits, and socioeconomic status were not considered. Regarding genetic factors in particular, the ALDH2 rs671 variant, East Asian-specific diversity, and APOE status are expected to have strong effects. The aim of KSS-2 is to examine the interactions of genetic background, lifestyle factors including drinking habit, socioeconomic status, and/or SVD markers for cognitive impairment, vascular disease, and death.

The KSS-2 is a prospective regional observational study of a healthy Japanese cohort that will clarify lifestyle habits to better maintain brain health from midlife by genotype. Japanese adults who underwent brain health checkups at their own expense are enrolled and will be followed-up for 10 years. We will extend the protocol of the KSS to include genetic background and potential confounding factors, including lifestyle (including drinking and exercise habit) and socioeconomic status, and perform survival analyses. The study outcomes are cognitive impairment, vascular events, and death.

We enrolled 908 healthy adults (mean age 64.2 years; range 35 to 84 years; 41% male) from September 1, 2018 until December 31, 2024.

This study will provide important insights into the development of individualized health intervention strategies.

The online version contains supplementary material available at https://doi.org/10.1265/ehpm.25-00135.